E-LIB Suche - Ergebnisse für: Garre, A

1

P1170 Long-term outcomes of newly diagnosed Inflammatory Bo..:

Chaparro, M ; Garre, A ; Núñez Ortiz, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2085-i2088 , 2024

Link: https://doi.org/10.1093/..

2

MO-0557 The virtual reality for managing emotional distress..:

Mico, S. ; Garcia, D. ; Ramos, M....
Radiotherapy and Oncology. 182 (2023) - p. S437-S438 , 2023

Link: https://doi.org/10.1016/..

3

OP20 Risk and predictors of surgery in a newly diagnosed co..:

Chaparro, M ; Garre, A ; Núñez Ortiz, A...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S018-S020 , 2021

Link: https://doi.org/10.1093/..

4

PO-1356 Dose constraints validation in moderate hypofractio..:

Maldonado, X. ; Altabas, M. ; Garre, J....
Radiotherapy and Oncology. 161 (2021) - p. S1113-S1114 , 2021

Link: https://doi.org/10.1016/..

5

P476 Effectiveness and safety of ustekinumab in ulcerative ..:

Chaparro, M ; Garre, A ; Iborra, M...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S465-S466 , 2021

Link: https://doi.org/10.1093/..

6

PD-0886 30-Day Mortality after Palliative Radiation Therapy..:

Vázquez Varela, M. ; Geng, A.A. ; Garre, J....
Radiotherapy and Oncology. 161 (2021) - p. S724-S725 , 2021

Link: https://doi.org/10.1016/..

7

P434 Effectiveness and safety of ustekinumab in ulcerative ..:

Chaparro, M ; Garre, A ; Iborra, M...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S394-S395 , 2020

Link: https://doi.org/10.1093/..

8

OP29 Tofacitinib in ulcerative colitis: Real-world evidence..:

Chaparro, M ; Garre, A ; Mesonero, F...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S026-S028 , 2020

Link: https://doi.org/10.1093/..

9

P744 Epidemiology, clinical characteristics, evolution and ..:

Chaparro, M ; Barreiro-de Acosta, M ; Benítez, J M...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S594-S597 , 2020

Link: https://doi.org/10.1093/..

10

Effectiveness and Safety of the Switch from Remicade® to CT..:

Chaparro, M ; Garre, A ; Guerra Veloz, M F...
Journal of Crohn's and Colitis. 13 (2019) 11 - p. 1380-1386 , 2019

Link: https://doi.org/10.1093/..

11

P790 Epidemiology, clinical characteristics, evolution and ..:

Chaparro, M ; Barreiro-de Acosta, M ; Benítez, J...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S516-S517 , 2019

Link: https://doi.org/10.1093/..

12

P666 Long-term effectiveness and safety of vedolizumab (VDZ..:

Chaparro, M ; Garre, A ; Alfaro, I...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S447-S448 , 2018

Link: https://doi.org/10.1093/..

13

P156 Differential characteristics of patients with inflamma..:

Chaparro, M ; Garre, A ; Ricart, E...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S174-S176 , 2018

Link: https://doi.org/10.1093/..

14

P397 Effectiveness of vedolizumab (VDZ) for the induction o..:

Chaparro, M ; Garre, A ; Alfaro, I...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S305-S306 , 2018

Link: https://doi.org/10.1093/..

15

P186 Association between anti-TNF serum levels and mucosal ..:

Chaparro, M. ; Barreiro-de Acosta, M. ; Echarri, A....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S171-S171 , 2017

Link: https://doi.org/10.1093/..